CNA Financial’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-39,530
Closed -$573K 172
2022
Q2
$573K Buy
39,530
+5,780
+17% +$98.5K 0.2% 111
2022
Q1
$882K Buy
33,750
+4,530
+16% +$129K 0.27% 92
2021
Q4
$1.16M Buy
29,220
+8,130
+39% +$371K 0.3% 82
2021
Q3
$1.05M Buy
21,090
+250
+1% +$13.6K 0.29% 94
2021
Q2
$1.16M Buy
20,840
+300
+1% +$16K 0.33% 84
2021
Q1
$961K Buy
20,540
+2,150
+12% +$104K 0.3% 99
2020
Q4
$801K Buy
18,390
+810
+5% +$29.9K 0.25% 122
2020
Q3
$643K Buy
17,580
+2,060
+13% +$70K 0.24% 112
2020
Q2
$453K Buy
+15,520
New +$429K 0.18% 130

Other funds holding HCAT

CNA Financial's HCAT Position: Q3 2022 in Review

CNA Financial sold out of Health Catalyst (HCAT) in Q3 2022, closing a stake of 39,530 shares — an estimated $573K sold.

CNA Financial first reported a position in HCAT in Q2 2020 and held it in 9 quarters. The position peaked at $1.16M in Q4 2021. 171 funds tracked by Wall St. Rank hold HCAT as of Q3 2022.

  • CNA Financial reported no remaining Health Catalyst position as of Q3 2022 after selling out during the quarter.
  • CNA Financial sold 39,530 Health Catalyst shares in Q3 2022, an estimated $573K.
  • CNA Financial first reported a position in Health Catalyst in Q2 2020 and held it in 9 quarters.
  • CNA Financial's Health Catalyst position peaked at $1.16M in Q4 2021.
  • 171 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2022.

Based on CNA Financial's 13F filing for Q3 2022, filed 10 Nov 2022.